Top Markets
#1 Arowana Arowana +10.12%
#2 Dual Dual +3.59%
#3 WYDE: End Hunger WYDE: End Hunger +2.19%
#4 SIXSEVEN SIXSEVEN +2.17%
#5 TENDIES TENDIES +1.30%
#6 Fabric Protocol Fabric Protocol +1.21%
#7 Orbs Orbs +1.10%
#8 Fractal Bitcoin Fractal Bitcoin +0.91%
#9 Smooth Love Potion Smooth Love Potion +0.89%
#10 Zerebro Zerebro +0.86%
Coin of the day
Arowana Arowana
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
CohBar, Inc. CohBar, Inc.

CohBar, Inc.

CWBR
Classifica tra le azioni #38304
CohBar Inc. is a clinical-stage biotechnology company dedicated to the... CohBar Inc. is a clinical-stage biotechnology company dedicated to the discovery and advancement of therapies that leverage mitochondrial biology, known as mitochondria-based therapeutics (MBTs). Their primary objective is to combat chronic conditions and diseases associated with aging. These MBTs are being developed to address a broad spectrum of medical challenges, including non-alcoholic steatohepatitis (NASH), obesity, fatty liver disease, idiopathic pulmonary fibrosis (IPF), type 2 diabetes, acute respiratory distress syndrome (ARDS), various cancers, and cardiovascular disorders like Alzheimer's disease. Their flagship clinical asset is CB4211, an innovative, optimized analogue of the MOTS-c mitochondrial-derived peptide. This candidate is currently undergoing Phase Ib evaluation as part of a larger Phase Ia/Ib clinical trial, specifically targeting non-alcoholic steatohepatitis (NASH) and obesity. Beyond their clinical work, CohBar's preclinical portfolio features CB5138 analogs aimed at fibrotic conditions, as well as CB5064 analogs being explored for their potential in treating ARDS linked to COVID-19. Established in 2007, CohBar, Inc. maintains its corporate headquarters in Menlo Park, California.
Prezzo delle azioni
$0.41
Ultima sincronizzazione: 2025-01-23
Capitalizzazione di mercato
$1.08M
Variazione (1 giorno)
0.00%
Variazione (1 anno)
0.00%
Paese
US
Scambia CohBar, Inc. (CWBR)

Categoria

Healthcare
Storico del rendimento da dividendi per CohBar, Inc. (CWBR)
Il rendimento da dividendi (TTM) di CohBar, Inc. (simbolo azionario: CWBR) al 2021-12-31 è: 0.00%
Rendimento medio negli ultimi 5 anni: 0.00%
Storico del rendimento da dividendi per CohBar, Inc. (CWBR) da 2011 a 2026
Rendimento da dividendi alla fine di ogni anno (TTM)
Anno Rendimento da dividendi Cambia
2026 (TTM) 0.00% 0.00%
2022 0.00% 0.00%
2021 0.00% 0.00%
2020 0.00% 0.00%
2019 0.00% 0.00%
2018 0.00% 0.00%
2017 0.00% 0.00%
2016 0.00% 0.00%
2015 0.00% 0.00%
2014 0.00% 0.00%
2013 0.00% 0.00%
2012 0.00% 0.00%
2011 0.00% 0.00%
Rendimenti da dividendi (TTM) di aziende simili o concorrenti
Azienda Rendimento da dividendi Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
0.00%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
0.65%
BE